Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market

Seeking to carve out its own niche in the obesity space, Syntis Bio launched on Tuesday to develop an oral weight-loss treatment that mimics the effects of gastric bypass surgery.